INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Tax withholdingVerified data

Barnes Wendy Lynn reported GDRX

Director, See Remarks · GoodRx Holdings, Inc. · Class A Common Stock

Side
F
Value
$163K
Shares
48.2K
Price
$3.38
Executed
Oct 15, 2026
Disclosed
Oct 15, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Oct 15 executedOct 15, 2026 disclosed

GDRX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
16/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+8 / 25

$163K reported value · 5.7% of prior position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GDRX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    HJ
    Hirsch Douglas JosephDirector
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    20.5K sh
    		Oct 26, 2026Oct 26, 2026
    traded Oct 26, 2026
    		+0dSEC FORM 4

    Evidence

    9
    HJ
    Hirsch Douglas JosephDirector
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    20.5K sh
    		Oct 26, 2026Oct 26, 2026
    traded Oct 26, 2026
    		+0dSEC FORM 4

    Evidence

    21
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    32.5K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$48K
    14.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    111.0K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    5,793 sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    51.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    5,793 sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    16
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$169K
    50.0K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    12
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$75K
    22.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    115.1K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    32.5K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    51.2K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    111.0K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    BL
    Barnes Wendy LynnDirector, See Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    115.1K sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$9,964
    2,948 sh
    		Oct 15, 2026Oct 15, 2026
    traded Oct 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    CT
    Chan Thomas (TC)Chief Accounting Officer
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    2,101 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    17
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    2,335 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Option exercise
    		M—
    2,335 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    9
    FJ
    Fengler JustinSee Remarks
    GDRXGoodRx Holdings, Inc.
    Tax withholding
    		F$3,645
    1,024 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001809519-26-000173
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 15, 2026
    Published
    Oct 15, 2026
    Ingested by INSIDER
    Nov 5, 02:11 UTC
    Last re-read
    Nov 5, 02:11 UTC

    Extracted facts

    Filer
    Barnes Wendy Lynn
    Role
    Director, See Remarks
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    GoodRx Holdings, Inc.
    Ticker
    GDRX
    Shares
    48.2K
    Price per share
    $3.38
    Value
    $162,926
    Execution date (reported)
    Oct 15, 2026
    Owned after transaction
    898.5K shares
    Days from execution to publication
    0

    Calculation

    Value = shares × reported price per share

    • Shares: 48.2K
    • Price: $3.38

    = $162,926

    What this establishes

    Barnes Wendy Lynn filed this Form 4 reporting a tax withholding of GDRX on Oct 15, 2026. It became public on Oct 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, See Remarks
    Barnes Wendy Lynncik:0002049585
    Issuer
    GoodRx Holdings, Inc.cik:0001809519

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.